Inactief instrument

Andere talen TearLab Corp Nasdaq

Aandelen

US8781932004

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

TearLab Corporation Announces Board Appointments	09-12-21
TearLab Corporation Appoints Adam Szaronos as Chief Executive Officer	09-12-21
Tearlab Corporation Appoints James V. Mazzo to the Company's Board of Directors	09-11-21
MellingMedical and TearLab Agreement Aims to Enhance Early Detection of Dry Eye Disease in American Veterans	16-09-21
TearLab Appoints Adam Szaronos as Chief Commercial Officer	28-07-20
TEARLAB CORP : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	09-07-20
Accelmed Partners II, fund managed by Accelmed Fund (Accelmed Partners) completed the acquisition of TearLab Corporation.	09-07-20
TearLab Corporation to Seek Acquisitions	09-07-20
TearLab: 1Q Earnings Snapshot	26-06-20
TEARLAB : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	26-06-20
Tearlab Corporation Reports Earnings Results for the First Quarter Ended March 31, 2020	26-06-20
TEARLAB : Entry into a Material Definitive Agreement (form 8-K/A)	08-06-20
TEARLAB CORP : Entry into a Material Definitive Agreement (form 8-K)	29-05-20
TEARLAB CORP : Submission of Matters to a Vote of Security Holders (form 8-K)	13-05-20
TEARLAB CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	12-05-20
TEARLAB CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	11-05-20
TEARLAB CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Unregistered Sale of Equity Securities, Changes in Control or Registrant, Other Events, Financial Statements and Exhibits (form 8-K)	11-05-20
TearLab Corporation Announces Board Appointments	11-05-20
Tearlab Mulls Inorganic Growth Opportunities	11-05-20
TearLab : Announces Acquisition By Accelmed Partners And Related $25 Million Investment	11-05-20

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen TearLab Corp Nasdaq

Aandelen

US8781932004

Andere talen

Filters